Mineralys Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.70 | -$0.70 | -$0.70 |
| Q2 2024 | 5 | -$0.88 | -$0.83 | -$0.86 |
| Q3 2024 | 3 | -$0.90 | -$0.90 | -$0.90 |
| Q1 2025 | 4 | -$0.84 | -$0.84 | -$0.84 |
| Q2 2025 | 4 | -$0.82 | -$0.82 | -$0.82 |
| Q1 2026 | 3 | -$3.62 | -$3.62 | -$3.62 |
Mineralys Therapeutics, Inc. Earnings Date And Information
Mineralys Therapeutics, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.83 earnings per share for the quarter, missing analysts' consensus estimates of $-0.73 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Mineralys Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.99 diluted earnings per share) and currently has a price-to-earnings ratio of -5.57. Mineralys Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Mineralys Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.73 | -$0.83 | -0.1 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.68 | -$0.70 | -0.02 | $0 | |
| 03/21/2024 | Q4 2023 | -$0.85 | -$0.61 | 0.24 | $0 | |
| 11/07/2023 | Q3 2023 | -$0.72 | -$0.55 | 0.17 | $0 | |
| 08/07/2023 | Q2 2023 | -$0.83 | -$0.30 | 0.53 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.71 | -$0.31 | 0.4 | $0 | |
| 03/15/2023 | Q4 2022 | $1.72 | -$0.22 | -1.94 | $0 | |
| 09/30/2022 | Q3 2022 | -$1,288.94 | $0 | |||
| 06/30/2022 | Q2 2022 | -$0.35 | $0 | |||
| 03/31/2022 | Q1 2022 | -$0.41 | $0 | |||
| 12/31/2021 | Q4 2021 | -$0.18 | $0 |
Mineralys Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Mineralys Therapeutics, Inc.'s earnings date?
Mineralys Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
How can I listen to Mineralys Therapeutics, Inc.'s earnings conference call?
The conference call for Mineralys Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Mineralys Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Mineralys Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Mineralys Therapeutics, Inc. generate each year?
Mineralys Therapeutics, Inc. (:MLYS) has a recorded net income of $0. Mineralys Therapeutics, Inc. has generated $-1.99 earnings per share over the last four quarters.
-
What is Mineralys Therapeutics, Inc.'s price-to-earnings ratio?
Mineralys Therapeutics, Inc. (:MLYS) has a price-to-earnings ratio of -5.57 and price/earnings-to-growth ratio is 0.23.
